论文部分内容阅读
最近,国家发改委价格司副司长周望军表示,尽管价格主管部门陆续降低了一大批药品的零售价格,但当前社会各方面普遍关心的看病贵、药价高问题并没有得到真正解决。据了解,目前纳入我国政府定价范围的药品共计2400余种,占市场流通药品数量的20%左右,占市场销售份额的60%左右。近年来,我国价格主管部门先后17次出台降价措施,降低了1100多种药品零售价格,降价总金额达到350多亿元。从
Recently, Zhou Wangjun, deputy director of Price Department of NDRC, said that although the price authorities gradually reduced the retail prices of a large number of pharmaceutical products, the problems of expensive medical care and high medicine prices, which are generally concerned by all sectors of society, have not been solved. It is understood that currently included in the scope of China’s government pricing drugs a total of more than 2400 species, accounting for about 20% of the market circulation of drugs, accounting for about 60% of market share. In recent years, China’s price authorities have introduced 17 price cuts measures, reducing the retail price of more than 1100 kinds of drugs, the total price cut reached 350 billion yuan. From